Experts debate whether European manufacturers are preferring domestic operations...
Large-scale integration of AI into pharma supply chains is on the way as compani...
Cell and gene therapies have undergone notable milestones in the last 12 months,...
Genentech’s label expansion for TNKase consolidates its market position for phar...
AstraZeneca's Imfinzi (durvalumab) plus chemotherapy, has gained CHMP recommenda...
During MWC Barcelona 2025 Huawei brought together customers & partners to explor...
At MWC Barcelona 2025, Li Peng delivered a keynote on how carriers can make the ...
The FDA has approved BeiGene’s Tevimbra with chemotherapy for treating oesophage...
ADCs are currently at the forefront of cancer treatment, but persistent drug dev...
Magnet Biomedicine has entered a partnership and licence agreement with Eli Lill...
New EU Clinical Trial Regulations simplify international trials while offering t...
As Rare Disease Day is commemorated on 28 February, experts discuss the barriers...
The CHMP has recommended the approval of AbbVie's upadacitinib (Rinvoq) for trea...
A survey has shown that pharma companies have low confidence their rare disease ...
Medigene and EpimAb Biotherapeutics have signed a co-development agreement invol...
With issues in therapy delivery and a barren trial landscape, short-term chances...
